-
2
-
-
0025610582
-
Chemotherapy for pancreatic cancer
-
Arbuck SG. Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol. 1990; 4: 953-968.
-
(1990)
Baillieres Clin Gastroenterol.
, vol.4
, pp. 953-968
-
-
Arbuck, S.G.1
-
3
-
-
77955715149
-
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
-
Faller BA, Burtness B. Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy. Biologics. 2009; 3: 419-428.
-
(2009)
Biologics.
, vol.3
, pp. 419-428
-
-
Faller, B.A.1
Burtness, B.2
-
5
-
-
34249933404
-
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
-
Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J ClinOncol. 2007; 25: 1960-1966.
-
(2007)
J ClinOncol.
, vol.25
, pp. 1960-1966
-
-
Moore, M.J.1
Goldstein, D.2
Hamm, J.3
-
6
-
-
0028927442
-
Nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts
-
Weterman MA, Ajubi N, van Dinter IM, et al. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer. 1995; 60: 73-81.
-
(1995)
Int J Cancer.
, vol.60
, pp. 73-81
-
-
Weterman, M.A.1
Ajubi, N.2
Van Dinter, I.M.3
-
7
-
-
77957809884
-
ADAM10 releases a soluble form of the GPNMB/osteoactivin extracellular domain with angiogenic properties
-
Rose AA, Annis MG, Dong Z, et al. ADAM10 releases a soluble form of the GPNMB/osteoactivin extracellular domain with angiogenic properties. PLoS One. 2010; 5: e12093.
-
(2010)
PLoS One.
, vol.5
, pp. e12093
-
-
Rose, A.A.1
Annis, M.G.2
Dong, Z.3
-
8
-
-
77955021117
-
DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells
-
Tomihari M, Chung JS, Akiyoshi H, et al. DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res. 2010; 70: 5778-5787.
-
(2010)
Cancer Res.
, vol.70
, pp. 5778-5787
-
-
Tomihari, M.1
Chung, J.S.2
Akiyoshi, H.3
-
9
-
-
33644747384
-
CR011, a fully human monoclonal antibody-auristatin e conjugate, for the treatment of melanoma
-
Tse KF, Jeffers M, Pollack VA, et al. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin Cancer Res. 2006; 12: 1373-1382.
-
(2006)
Clin Cancer Res.
, vol.12
, pp. 1373-1382
-
-
Tse, K.F.1
Jeffers, M.2
Pollack, V.A.3
-
10
-
-
77952237462
-
GPNMB expression in uveal melanoma: A potential for targeted therapy
-
Williams MD, Esmaeli B, Soheili A, et al. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 2010; 20: 184-190.
-
(2010)
Melanoma Res.
, vol.20
, pp. 184-190
-
-
Williams, M.D.1
Esmaeli, B.2
Soheili, A.3
-
11
-
-
33646230317
-
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme
-
Kuan CT, Wakiya K, Dowell JM, et al. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res. 2006; 12: 1970-1982.
-
(2006)
Clin Cancer Res.
, vol.12
, pp. 1970-1982
-
-
Kuan, C.T.1
Wakiya, K.2
Dowell, J.M.3
-
12
-
-
0242690379
-
Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells
-
Onaga M, Ido A, Hasuike S, et al. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol. 2003; 39: 779-785.
-
(2003)
J Hepatol.
, vol.39
, pp. 779-785
-
-
Onaga, M.1
Ido, A.2
Hasuike, S.3
-
13
-
-
84879639061
-
Upregulation of glycoprotein nonmetastaticB by colony-stimulating factor-1 and epithelial cell adhesion molecule in hepatocellular carcinoma cells
-
Tian F, Liu C, Wu Q, et al.Upregulation of glycoprotein nonmetastaticB by colony-stimulating factor-1 and epithelial cell adhesion molecule in hepatocellular carcinoma cells. Oncol Res. 2013; 20: 341-350.
-
(2013)
Oncol Res.
, vol.20
, pp. 341-350
-
-
Tian, F.1
Liu, C.2
Wu, Q.3
-
14
-
-
84905321759
-
Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner
-
Eldai H, Periyasamy S, Al Qarni S, et al. Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner. PLoS One. 2013; 8: e76251.
-
(2013)
PLoS One.
, vol.8
, pp. e76251
-
-
Eldai, H.1
Periyasamy, S.2
Al Qarni, S.3
-
15
-
-
84880109599
-
Glycoprotein non-metastatic b (GPNMB): Ametastaticmediator and emerging therapeutic target in cancer
-
Maric G, Rose AA, Annis MG, et al. Glycoprotein non-metastatic b (GPNMB): ametastaticmediator and emerging therapeutic target in cancer. Onco Targets Ther. 2013; 6: 839-852.
-
(2013)
Onco Targets Ther.
, vol.6
, pp. 839-852
-
-
Maric, G.1
Rose, A.A.2
Annis, M.G.3
-
16
-
-
77950670628
-
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
-
Rose AA, Grosset AA, Dong Z, et al. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res. 2010; 16: 2147-2156.
-
(2010)
Clin Cancer Res.
, vol.16
, pp. 2147-2156
-
-
Rose, A.A.1
Grosset, A.A.2
Dong, Z.3
-
17
-
-
77950670628
-
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
-
Rose AAN, Grosset AA, Dong ZF, et al. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res. 2010; 16: 2147-2156.
-
(2010)
Clin Cancer Res.
, vol.16
, pp. 2147-2156
-
-
Aan, R.1
Grosset, A.A.2
Dong, Z.F.3
-
18
-
-
43649099521
-
Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate
-
Qian XZ, Mills E, Torgov M, et al. Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate. Mol Oncol. 2008; 2: 81-93.
-
(2008)
Mol Oncol.
, vol.2
, pp. 81-93
-
-
Qian, X.Z.1
Mills, E.2
Torgov, M.3
-
19
-
-
17344392308
-
A new mathematical model for relative quantification in real-time RT-PCR
-
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45.
-
(2001)
Nucleic Acids Res.
, vol.29
, pp. e45
-
-
Pfaffl, M.W.1
-
20
-
-
84880869807
-
The complexity of NF-kappaB signaling in inflammation and cancer
-
Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer. 2013; 12: 86.
-
(2013)
Mol Cancer.
, vol.12
, pp. 86
-
-
Hoesel, B.1
Schmid, J.A.2
-
21
-
-
84920035203
-
Role of WWOX and NF-kappaB in lung cancer progression
-
Chen S-J, Huang S-S, Chang N-S. Role of WWOX and NF-kappaB in lung cancer progression. Transl Respir Med. 2013; 1(1): 15.
-
(2013)
Transl Respir Med.
, vol.1
, Issue.1
, pp. 15
-
-
Chen, S.-J.1
Huang, S.-S.2
Chang, N.-S.3
-
22
-
-
85039888256
-
Effect of GPNMB on proliferation, apoptosis and invasion of human hepatoma cells
-
Zhang CY, Xie X, Zhang CX. Effect of GPNMB on proliferation, apoptosis and invasion of human hepatoma cells. Chin J Pathophysiol. 2013; 29: 1441-1446.
-
(2013)
Chin J Pathophysiol.
, vol.29
, pp. 1441-1446
-
-
Zhang, C.Y.1
Xie, X.2
Zhang, C.X.3
-
23
-
-
84872480731
-
C-FLIP, a master anti-apoptotic regulator
-
Safa AR. c-FLIP, a master anti-apoptotic regulator. Exp Oncol. 2012; 34: 176-184.
-
(2012)
Exp Oncol.
, vol.34
, pp. 176-184
-
-
Safa, A.R.1
-
24
-
-
40449136380
-
Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors
-
Vucic D. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors. Curr Cancer Drug Targets. 2008; 8: 110-117.
-
(2008)
Curr Cancer Drug Targets.
, vol.8
, pp. 110-117
-
-
Vucic, D.1
-
25
-
-
79952708318
-
Caspase-8 and bid: Caught in the act between death receptors and mitochondria
-
Kantari C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta. 2011; 1813: 558-563.
-
(2011)
Biochim Biophys Acta.
, vol.1813
, pp. 558-563
-
-
Kantari, C.1
Walczak, H.2
-
26
-
-
84856698334
-
BCL2A1: The underdog in the BCL2 family
-
Vogler M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ. 2012; 19: 67-74.
-
(2012)
Cell Death Differ.
, vol.19
, pp. 67-74
-
-
Vogler, M.1
-
27
-
-
0038521296
-
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model
-
Rich JN, Shi Q, Hjelmeland M, et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem. 2003; 278: 15951-15957.
-
(2003)
J Biol Chem.
, vol.278
, pp. 15951-15957
-
-
Rich, J.N.1
Shi, Q.2
Hjelmeland, M.3
-
28
-
-
84896494492
-
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity
-
Fiorentini C, Bodei S, Bedussi F, et al. GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. Exp Cell Res. 2014; 323: 100-111.
-
(2014)
Exp Cell Res.
, vol.323
, pp. 100-111
-
-
Fiorentini, C.1
Bodei, S.2
Bedussi, F.3
-
29
-
-
36849076668
-
Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3 T3 fibroblasts
-
Furochi H, Tamura S, MameokaM, et al. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3 T3 fibroblasts. FEBS Lett. 2007; 581: 5743-5750.
-
(2007)
FEBS Lett.
, vol.581
, pp. 5743-5750
-
-
Furochi, H.1
Mameokam, T.S.2
-
30
-
-
0030744988
-
Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells
-
Yee J, Kuncio GS, Bhandari B, et al. Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells. Kidney Int. 1997; 52: 120-129.
-
(1997)
Kidney Int.
, vol.52
, pp. 120-129
-
-
Yee, J.1
Kuncio, G.S.2
Bhandari, B.3
-
31
-
-
33846048058
-
Transcription factors control invasion: AP-1 the first among equals
-
Ozanne BW, Spence HJ, McGarry LC, et al. Transcription factors control invasion: AP-1 the first among equals. Oncogene. 2007; 26: 1-10.
-
(2007)
Oncogene.
, vol.26
, pp. 1-10
-
-
Ozanne, B.W.1
Spence, H.J.2
McGarry, L.C.3
-
32
-
-
0032943591
-
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
-
Wang WX, Abbruzzese JL, Evans DB, et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res. 1999; 5: 119-127.
-
(1999)
Clin Cancer Res.
, vol.5
, pp. 119-127
-
-
Wang, W.X.1
Abbruzzese, J.L.2
Evans, D.B.3
-
33
-
-
1842850737
-
Increased expression of NF-kappa B subunits in human pancreatic cancer cells
-
Chandler NM, Canete JJ, Callery MP. Increased expression of NF-kappa B subunits in human pancreatic cancer cells. J Surg Res. 2004; 118: 9-14.
-
(2004)
J Surg Res.
, vol.118
, pp. 9-14
-
-
Chandler, N.M.1
Canete, J.J.2
Callery, M.P.3
-
34
-
-
0037780982
-
Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer
-
Liptay S, Weber CK, Ludwig L, et al. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J Cancer. 2003; 105: 735-746.
-
(2003)
Int J Cancer.
, vol.105
, pp. 735-746
-
-
Liptay, S.1
Weber, C.K.2
Ludwig, L.3
-
35
-
-
0346993732
-
Identification and characterization of the genes encoding human and mouse osteoactivin
-
Owen TA, Smock SL, Prakash S, et al. Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr. 2003; 13: 205-220.
-
(2003)
Crit Rev Eukaryot Gene Expr.
, vol.13
, pp. 205-220
-
-
Owen, T.A.1
Smock, S.L.2
Prakash, S.3
-
36
-
-
34248226374
-
Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses
-
Ripoll VM, Irvine KM, Ravasi T, et al. Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol. 2007; 178: 6557-6566.
-
(2007)
J Immunol.
, vol.178
, pp. 6557-6566
-
-
Ripoll, V.M.1
Irvine, K.M.2
Ravasi, T.3
-
37
-
-
0037631651
-
MRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris
-
Bachner D, Schroder D, Gross G. mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris. Brain Res Gene Expr Patterns. 2002; 1: 159-165.
-
(2002)
Brain Res Gene Expr Patterns.
, vol.1
, pp. 159-165
-
-
Bachner, D.1
Schroder, D.2
Gross, G.3
-
38
-
-
84863745351
-
Gpnmb/osteoactivin, an attractive target in cancer immunotherapy
-
Zhou LT, Liu FY, Li Y, et al. Gpnmb/osteoactivin, an attractive target in cancer immunotherapy. Neoplasma. 2012; 59: 1-5.
-
(2012)
Neoplasma.
, vol.59
, pp. 1-5
-
-
Zhou, L.T.1
Liu, F.Y.2
Li, Y.3
-
39
-
-
59349101632
-
A phase I/II study of CR011-vcMMAE, an antibody toxin conjugate drug, in patients with unresectable stage III/IV melanoma
-
Hwu P, Sznol M, Kluger H, et al. A phase I/II study of CR011-vcMMAE, an antibody toxin conjugate drug, in patients with unresectable stage III/IV melanoma. J Clin Oncol. 2008; 26: 9029.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 9029
-
-
Hwu, P.1
Sznol, M.2
Kluger, H.3
-
40
-
-
77950819962
-
A phase (Ph) I/II study of CR011-VcMMAE, an antibody-drug conjugate, in patients (Pts) with locally advanced or metastatic breast cancer (MBC)
-
Burris H, Saleh M, Bendell J, et al. A phase (Ph) I/II study of CR011-VcMMAE, an antibody-drug conjugate, in patients (Pts) with locally advanced or metastatic breast cancer (MBC). Cancer Res. 2009; 69: 855s-855s.
-
(2009)
Cancer Res.
, vol.69
, pp. 855s-855s
-
-
Burris, H.1
Saleh, M.2
Bendell, J.3
-
41
-
-
77952239035
-
A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate (ADC) targeting glycoprotein NMB (GPNMB) in patients (pts) with advanced melanoma
-
Hwu P, SznolM, Pavlick A, et al. A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate (ADC) targeting glycoprotein NMB (GPNMB) in patients (pts) with advanced melanoma. J Clin Oncol. 2009; 27: 9032.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 9032
-
-
Hwu, P.1
Sznolm Pavlick, A.2
-
42
-
-
75149134295
-
A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate, in patients (pts) with locally advanced or metastatic breast cancer (MBC)
-
Peacock N, Saleh M, Bendell J, et al. A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate, in patients (pts) with locally advanced or metastatic breast cancer (MBC). J Clin Oncol. 2009; 27: 1067.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 1067
-
-
Peacock, N.1
Saleh, M.2
Bendell, J.3
|